Showing 141 - 160 results of 20,793 for search '"therapy"', query time: 0.05s Refine Results
  1. 141
  2. 142
  3. 143

    Iron Chelation Therapy in Myelodysplastic Syndromes by Emanuela Messa, Daniela Cilloni, Giuseppe Saglio

    Published 2010-01-01
    “…In low-risk patients, transfusion dependency can be long lasting, leading to iron overload. Iron chelation therapy may be a therapeutic option for these patients, especially since the approval of oral iron chelators, which are easier to use and better accepted by the patients. …”
    Get full text
    Article
  4. 144
  5. 145
  6. 146
  7. 147
  8. 148
  9. 149
  10. 150
  11. 151

    Understanding and Prevention of “Therapy-” Induced Dyskinesias by Iciar Aviles-Olmos, Zinovia Kefalopoulou, Thomas Foltynie

    Published 2012-01-01
    “…However, the spectre of dyskinesia in the absence of L-dopa, the so-called “off-phase” or graft-induced dyskinesia (GID), remains a major obstacle particularly in the further development of cell therapy in PD, but it is also a concern for proponents of gene therapy approaches. …”
    Get full text
    Article
  12. 152
  13. 153

    Amodiaquine and Ciprofloxacin Combination in Plasmodiasis Therapy by Peace Mayen Edwin Ubulom, Chinweizu Ejikeme Udobi, Mark Iheukwumere Madu

    Published 2015-01-01
    “…Conversely, the combination therapy of Amodiaquine and Ciprofloxacin had a significant antiplasmodial effect at all the doses administered. …”
    Get full text
    Article
  14. 154
  15. 155

    CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS by Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone

    Published 2024-01-01
    “…Chimeric antigen receptor (CAR)-T cell therapy targeting B-cell antigens, such as CD19 or CD20, is emerging as an efficacious treatment for R/R follicular lymphoma patients, particularly for those with early relapse and refractory to alkylating agents and to anti-CD20 monoclonal antibodies, resulting in a high rate of durable responses in a high proportion of patients.   …”
    Get full text
    Article
  16. 156
  17. 157

    The Clinical Cost of Delays in Switching Therapy by Sharon Walmsley

    Published 2007-01-01
    “…New guidelines suggest that the goal of therapy should be maximal virological suppression. …”
    Get full text
    Article
  18. 158

    The Role of Bridging Therapy in Hepatocellular Carcinoma by Roberto Galuppo, Angie McCall, Roberto Gedaly

    Published 2013-01-01
    “…We are also presenting our single-center experience of 96 patients undergoing transplantation for HCC with and without bridging therapy.…”
    Get full text
    Article
  19. 159

    Infusion therapy for chronic liver diseases by I. A. Kurkina, M. V. Mayevskaya, I. N. Tikhonov, V. N. Zozulya, V. I. Leschenko

    Published 2018-08-01
    “…To present modern options of comprehensive infusion therapy at various liver diseases, indications and contraindications for application of basic blood substitute groups, and pathogenically justified approaches for their use. …”
    Get full text
    Article
  20. 160

    Use of Pie Charts in Cognitive Therapies by Melis SEDEF KAHRAMAN, Sebnem SAHINOZ, Seher Olga GURIZ

    Published 2016-04-01
    Subjects: “…Cognitive Therapy…”
    Get full text
    Article